Abstract
In the present study, we aimed to determine whether cytidine-5′-diphosphatecholine (CDP-choline or citicoline) can improve the outcome of short-term myocardial ischemia–reperfusion injury in rats. Ischemia was produced in anesthetized rats by ligature of the left anterior descending coronary artery for 7 min followed by a reperfusion period of 7 min. Reperfusion-induced ventricular tachycardia (VT), ventricular fibrillation (VF), survival rate, and changes in arterial pressure were evaluated. Saline (1 ml/kg), CDP-choline (100, 250,and 500 mg/kg), or lidocaine (5 mg/kg) was intravenously injected in the middle of the ischemic period. Intracerebroventricular (i.c.v.) mecamylamine (50 µg) or atropine sulfate (10 µg) pretreatments were made 10 min before the coronary occlusion period. Pretreatment with intravenous (i.v.) atropine methylnitrate (2 and 5 mg/kg; i.v.) or bilateral vagotomy was performed 5 min before the induction of ischemia. An in vivo microdialysis study was performed in the nucleus ambiguus area (NA); choline and acetylcholine levels were measured in extracellular fluids. In control rats, VT, VF, and lethality were observed in 85%, 60% and 50% of the animals, respectively. Intravenous CDP-choline produced a short-term increase in blood pressure and reduced the incidence of VT, VF, and lethality dose-dependently when injected in the middle of the ischemic period. CDP-choline at doses of 250 and 500 mg/kg completely prevented death. Intracerebroventricular atropine sulfate pretreatment completely abolished the protective effect of CDP-choline, while mecamylamine pretreatment had no effect on the drug. CDP-choline increased the levels of extracellular choline and acetylcholine in the NA area. Bilateral vagotomy completely abolished the protective effect of CDP-choline in the reperfusion period. Moreover, the intravenous pretreatment with atropine methylnitrate produced dose-dependent blockade in the reduction of VT, VF, and mortality rates induced by CDP-choline. Neither of these pretreatments except mecamylamine affected the pressor effect of CDP-choline. Intracerebroventricular mecamylamine attenuated the increase in blood pressure induced by CDP-choline. In conclusion, intravenously injected CDP-choline prevents cardiac arrhythmias and death induced by short-term myocardial ischemia–reperfusion injury. Activation of central muscarinic receptors and vagal pathways mediates the protective effect of CDP-choline. The protective effect of CDP-choline is not related to its pressor effect.
Similar content being viewed by others
References
Adibhatla RM, Hatcher JF (2005) Cytidine 5′-diphosphocholine (CDP-choline) in stroke and other CNS disorders. Neurochem Res 30:15–23
Adibhatla RM, Hatcher JF, Dempsey RJ (2002) Citicoline: neuroprotective mechanisms in cerebral ischemia. J Neurochem 80:12–23
Adibhatla RM, Hatcher JF, Larsen EC, Chen X, Sun D, Tsao FH (2006) CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine cytidylyltransferase after stroke. J Biol Chem 81:6718–6725
Ando M, Katare RG, Kakinuma Y, Zhang D, Yamasaki F, Muramoto K, Sato T (2005) Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein. Circulation 112:164–170
Bernik T, Friedman SG, Ochani M, DiRaimo R, Susarla S, Czura CJ, Tracey KJ (2002) Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 36:1231–1236
Blusztajn JK, Wurtman RJ (1983) Choline and cholinergic neurons. Science 221:614–619
Cansev M (2006) Uridine and cytidine in the brain: their transport and utilization. Brain Res Rev 52:389–397
Cavun S, Savci V (2004) CDP-choline increases plasma ACTH and potentiates the stimulated release of GH, TSH and LH: the cholinergic involvement. Fundam Clin Pharmacol 18:513–523
Cavun S, Savci V, Ulus IH (2004) Centrally injected CDP-choline increases plasma vasopressin levels by central cholinergic activation. Fundam Clin Pharmacol 18:71–77
Cheng Z, Zhang H, Guo SZ, Wurster R, Gozal D (2004) Differential control over postganglionic neurons in rat cardiac ganglia by NA and DmnX neurons: anatomical evidence. Am J Physiol Regul Integr Comp Physiol 286:625–633
De Jonge WJ, Van der Zanden EP, The FO, Bijlsma MF, Van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, Van den Wijngaard RM, Boeckxstaens GE (2005) Stimulation of vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6(8):844–851
Dobelis P, Madl JE, Pfister JA, Manners GD, Walrond JP (1999) Effect of Delphinium alkaloids on neuromuscular transmission. J Pharm Exp Ther 291:538–546
Jones JF (2001) Vagal control of the rat heart. Exp Physiol 86:797–801
Kakinuma Y, Ando M, Kuwabara M, Katare RG, Okudela K, Kobayashi M, Sato T (2005) Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non-hypoxic induction of HIF-1alpha. FEBS Lett 579:2111–2118
Kawashima K, Fuji T (2003) The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci 74:675–696
Lopez G-Coviella I, Agut J, Von Borstel R, Wurtman RJ (1987) Metabolism of cytidine (5′)-diphosphocholine (CDP-choline) following oral and intravenous administration to the human and the rat. Neurochem Int 11:293–297
Lopez G-Coviella I, Agut J, Savcı V, Ortiz AJ, Wurtman RJ (1995) Evidence that 5′-cytidinediphosphocholine can affect brain phospholipid composition by increasing choline and cytidine plasma levels. J Neurochem 65:889–894
Mioni C, Bazzani C, Giuliani G, Altavilla D, Leone S, Ferrari A, Minutoli L, Bitto A, Marini H, Zaffe D, Boticelli AR, Iannone A, Tomasi A, Bigiani A, Bertolini A, Squadrito F, Guarini S (2005) Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia–reperfusion injury in rats. Crit Care Med 33:2621–2628
Newman MB, Arendash GW, Shytle RD, Bickford PC, Tighe T, Sanberg PR (2002) Nicotine’s oxidative and antioxidant properties in CNS. Life Sci 71:2807–2820
Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates. Academic Press, New York
Savci V, Cavun S, Goktalay G, Ulus IH (2002) Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system. Naunyn-Schmiedeberg’s Arch Pharmacol 365:388–398
Savci V, Goktalay G, Cansev M, Cavun S, Yilmaz MS, Ulus IH (2003) Intravenously injected CDP-choline increases blood pressure and reverses hypotension in haemorrhagic shock: effect is mediated by central cholinergic activation. Eur J Pharmacol 468:129–139
Secades JJ, Lorenzo JL (2006) Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol 28(Suppl B):1–56
Stegelmeier BL, Hall JO, Gardner DR, Panter KE (2003) The toxicity and kinetics of larkspur alkaloid, methyllycaconitine, in mice. J Anim Sci 81:1237–1241
Vanoli E, De Ferrai GM, Stramba-Badiale M, Hull SS, Foreman RD, Schwartz PJ (1991) Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 68:1471–1481
Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DW (1988) The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction and reperfusion. Cardiovasc Res 22:447–455
Wang Y, Su DM, Wang RH, Liu Y, Wang H (2005) Antinociceptive effects of choline against acute and inflammatory pain. Neuroscience 131:49–56
Weiss GB (1995) Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Sci 56:637–660
Wurtman RJ, Regan M, Ulus IH, Yu L (2000) Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol 60:989–992
Yang B, Lin H, Xu C, Liu Y, Wang H, Han H, Wang Z (2005) Choline produces cytoprotective effects against ischemic myocardial injuries: Evidence for the role of cardiac M3 subtype muscarinic acetylcholine receptors. Cell Physiol Biochem 16:163–174
Yilmaz MS, Yalcin M, Savci V (2006) Cytidine 5′-diphosphocholine restores blood flow of superior mesenteric and renal arteries and prolongs survival time in haemorrhaged anaesthetised rats. Clin Exp Pharmacol Physiol 33:415–420
Zuanetti G, De Ferrai GM, Priori SG, Schwartz PJ (1987) Protective effect of vagal stimulation on reperfusion arrhythmias in cats. Circ Res 61:429–435
Acknowledgment
This study was supported by the grant from Scientific Research Foundation of Uludag University (2003/31). We are grateful to Cagatay Buyukuysal (Uludag University Faculty of Medicine, Department of Bioistatistic) for his valuable help with the statistical analysis. We would like to thank Dr. Daryl Henderson for his kind help in editing our manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yilmaz, M.S., Coskun, C., Yalcin, M. et al. CDP-choline prevents cardiac arrhythmias and lethality induced by short-term myocardial ischemia–reperfusion injury in the rat: involvement of central muscarinic cholinergic mechanisms. Naunyn-Schmied Arch Pharmacol 378, 293–301 (2008). https://doi.org/10.1007/s00210-008-0300-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-008-0300-0